Colombian Consensus on the Treatment of Placenta Accreta Spectrum (PAS)

Authors

DOI:

https://doi.org/10.18597/rcog.3877

Keywords:

Placenta accreta, consensus conference, developing countries, healthcare resources

Abstract

Introduction: Placenta accreta spectrum (PAS) is a condition associated with massive postpartum bleeding and maternal mortality. Management guidelines published in high income countries recommend the participation of interdisciplinary teams in hospitals with sufficient resources for performing complex procedures. However, some of the recommendations contained in those guidelines are difficult to implement in low and medium income countries.
Objectives: The aim of this consensus is to draft general recommendations for the treatment of PAS in Colombia.
Materials and methods: Twenty-three panelists took part in the consensus with their answers to 31 questions related to the treatment of PAS. The panelists were selected based on participation in two surveys designed to determine the resolution capabilities of national and regional hospitals. The modified Delphi methodology was used, introducing two successive discussion rounds. The opinions of the participants, with a consensus of more than 80%, as well as implementation barriers and facilitators, were taken into consideration in order to issue the recommendations.
Results: The consensus draftedfive recommendations, integrating the answers of the panelists. 
Recommendation 1. Primary care institutions must undertake active search of PAS in patients with risk factors: placenta praevia and history of myomectomy or previous cesarean section. In case of ultrasound signs suggesting PAS, patients must be immediately referred, without a minimum gestational age, to hospitals recognized as referral centers. Online communication and care modalities may facilitate the interaction between primary care institutions and referral centers for PAS. The risks and benefits of telemedicine modalities must be weighed.
Recommendation 2. Referral hospitals for PAS need to be defined in each region of Colombia, ensuring coverage throughout the national territory. It is advisable to concentrate the flow of patients affected by this condition in a few hospitals with surgical teams specifically trained in PAS, availability of specialized resources, and institutional efforts at improving quality of care with the aim of achieving better health outcomes in pregnant women with this condition. To achieve this goal, participants recommend that healthcare regulatory agencies at a national and regional level should oversee the process of referral for these patients, expediting administrative pathways in those cases in which there is no prior agreement between the insurer and the selected hospital or clinic.
Recommendation 3. Referral centers for patients with PAS are urged to build teams consisting of a fixed group of specialists (obstetricians, urologists, general surgeons, interventional radiologists) entrusted with the care of all PAS cases. It is advisable for these interdisciplinary teams to use the “intervention bundle” model as a guidance for building PAS referral centers. This model comprises the following activities: service preparedness, disease prevention and identification, response to the occurrence of the disease, and debriefing after every event. Telemedicine facilitates PAS treatment and should be taken into consideration by interdisciplinary teams caring for this disease.
Recommendation 4. Obstetrics residents must be instructed in the performance of maneuvers that are useful for the prevention and treatment of massive intraoperative bleeding due to placenta praevia and PAS, including manual aortic compression, uterine tourniquet, pelvic packing, retrovesical bypass, and Ward maneuver. Specialization Obstetrics and Gynecology programs in Colombia must include the basic concepts of the diagnosis and treatment of PAS. Referral centers for PAS must offer online and in-person training programs for professionals interested in improving their competencies in PAS. Moreover, they must offer permanent remote support (telemedicine) to other hospitals in their region for patients with this condition.
Recommendation 5. Patients suspected of having PAS and placenta praevia based on imaging, with no evidence of active vaginal bleeding, must be delivered between weeks 34 and 36 6/7. Surgical treatment must include sequential interventions that may vary depending on the characteristics of the lesion, the clinical condition of the patient and the availability of resources. The surgical options (total and subtotal hysterectomy, one-stage conservative surgical management and watchful waiting) must be included in a protocol known by the entire interdisciplinary team. In situations in which an antepartum diagnosis is lacking, that is to say, in the face of intraoperative finding of PAS (evidence of purple bulging or neovascularization of the anterior aspect of the uterus), and the participation of untrained personnel, three options are considered:
Option 1: In the absence of indication of immediate delivery or of vaginal delivery, the recommendation is to postpone the cesarean section (close the laparotomy before incising the uterus) until the recommended resources for safe surgery are secured.
Option 2: If there is an indication for immediate delivery (e.g., non-reassuring fetal status) but there is absence of vaginal bleeding or indication for immediate PAS management, a two-stage management is suggested: cesarean section avoiding placental incision, followed by uterine repair and abdominal closure, until the availability of the recommended resources for safe surgery is ascertained.
Option 3: In the event of vaginal bleeding that prevents definitive PAS management, the fetus must be delivered through the uterine fundus, followed by uterine repair and reassessment of the situation. Sometimes, fetal delivery diminishes placental flow and vaginal bleeding is reduced or disappears, enabling the possibility to postpone definitive management of PAS. In case of persistent significant bleeding, hysterectomy should be performed, using all available resources: manual aortic compression, immediate call to the surgeons with the best available training, telemedicine support from expert teams in other hospitals. If a patient with risk factors for PAS (e.g., myomectomy or previous cesarean section) has a retained placenta after vaginal delivery, it is advisable to confirm the possibility of such diagnosis (by means of ultrasound, for example) before proceeding to manual extraction of the placenta.
Conclusions: It is our hope that this first Colombian consensus on PAS will serve as a basis for additional discussions and collaborations that can result in improved clinical outcomes for women affected by this condition. Additional research will be required in order to evaluate the applicability and effectiveness of these recommendations.

Author Biographies

Albaro José Nieto-Calvache, Fundación Valle de Lili, Cali (Colombia).

Clínica de Espectro de Acretismo Placentario, Fundación Valle de Lili, Cali (Colombia).

José Enrique Sanín-Blair, Clínica el Rosario, Medellín (Colombia).

Unidad de Medicina Materno Fetal, Clínica Universitaria Bolivariana / Clínica el Rosario, Medellín (Colombia).

Haidi Marcela Buitrago-Leal, ASBOG, Bogotá (Colombia).

Medicina Materno Fetal - Epidemiología. Departamento de Gineco Obstetricia, División de Medicina Materno Fetal, Clínica de la Mujer Grupo Quirón Salud/Country/Colina. Bogotá (Colombia). Coordinadora Comité Salud Materno Perinatal – ASBOG, Bogotá (Colombia).

Jesús Andrés Benavides-Serralde, Fundación Universitaria Autónoma de las Américas, Pereira (Colombia).

Unidad de Medicina Materno Fetal Perinatal Care IPS. Servicio de Ginecología y Obstetricia, Clínica San Rafael. Departamento de Ginecología y Obstetricia, Fundación Universitaria Autónoma de las Américas, Pereira (Colombia).

Juliana Maya-Castro, Universidad ICESI, Cali (Colombia).

Facultad de Ciencias de la Salud, Universidad ICESI, Cali (Colombia).

Adda Piedad Rozo-Rangel, Fundación Universitaria de Ciencias de la Salud, Bogotá (Colombia).

Hospital San José, Fundación Universitaria de Ciencias de la Salud, Bogotá (Colombia).

Adriana Messa-Bryon, Fundación Valle de Lili, Cali (Colombia).

Clínica de Espectro de Acretismo Placentario, Fundación Valle de Lili, Cali (Colombia).

Alejandro Colonia-Toro, Hospital General de Medellín, Medellín (Colombia).

Hospital General de Medellín, Medellín (Colombia).

Armando Rafael Gómez-Castro, Clínica la Misericordia, Barranquilla (Colombia).

Clínica la Misericordia, Barranquilla (Colombia).

Arturo Cardona-Ospina, Clínica del Prado, Grupo Quirón Salud, Medellín (Colombia).

Clínica del Prado, Grupo Quirón Salud, Medellín (Colombia).

Carlos Eduardo Caicedo-Cáceres, Universidad Antonio Nariño, Bogotá (Colombia).

Subred integrada de Servicios de Salud Centro Oriente E.S.E., Universidad Antonio Nariño, Bogotá (Colombia).

Elkin Fabian Dorado-Roncancio, Hospital Federico Lleras Acosta, Ibagué (Colombia).

Hospital Federico Lleras Acosta, Ibagué (Colombia).

Jaime Luis Silva, Pontificia Universidad Javeriana, Bogotá (Colombia).

Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá (Colombia).

Javier Andrés Carvajal-Valencia, Fundación Valle de Lili, Cali (Colombia).

Clínica de Espectro de Acretismo Placentario, Fundación Valle de Lili, Cali (Colombia).

Jesús Arnulfo Velásquez-Penagos, Universidad de Antioquia, Medellín (Colombia).

Hospital Universitario San Vicente Fundación, Universidad de Antioquia, Medellín (Colombia).

Jorge Ernesto Niño-González, Hospital Universitario Clínica San Rafael, Bogotá (Colombia).

Hospital Universitario Clínica San Rafael, Bogotá (Colombia).

Juan Manuel Burgos-Luna, Fundación Valle de Lili, Cali (Colombia).

Clínica de Espectro de Acretismo Placentario, Fundación Valle de Lili, Cali (Colombia).

Juan Carlos Rincón-García, Hospital Universitario San Rafael, Clínica Medilaser, Tunja (Colombia).

Hospital Universitario San Rafael, Clínica Medilaser, Tunja (Colombia).

Lía Matera-Torres, Universidad de Cartagena, Cartagena (Colombia).

Centro Hospitalario Serena del Mar, Universidad de Cartagena, Cartagena (Colombia).

Orlando Afranio Villamizar-Galvis, Clínica Santa Ana, Cúcuta (Colombia).

Clínica Santa Ana, Cúcuta (Colombia).

Sandra Ximena Olaya-Garay, Hospital Universitario SES de Caldas, Manizales (Colombia).

Hospital Universitario SES de Caldas, Manizales (Colombia).

Virna Patricia Medina-Palmezano, Clínica Imbanaco Grupo Quirón Salud, Cali (Colombia).

Clínica Imbanaco Grupo Quirón Salud, Cali (Colombia).

Jimmy Castañeda, Federación Colombiana de Obstetricia y Ginecología (FECOLSOG), Bogotá (Colombia).

Jimmy Castañeda, MD. Director de Educación, Federación Colombiana de Obstetricia y Ginecología (FECOLSOG), Bogotá (Colombia).

References

Jauniaux E, Hussein AM, Einerson BD, Silver RM. Debunking 20th century myths and legends about the diagnosis of placenta accreta spectrum. Ultrasound Obstet Gynecol. 2022;59(4):417-23. https://doi.org/10.1002/uog.24890

Jauniaux E, Ayres-de-Campos D, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. Int J Gynaecol Obstet. 2018;140(3):261-4. https://doi.org/10.1002/ijgo.12406

Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, Fox KA, Collins S; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;146(1):20-24. https://doi.org/10.3109/14767058.2011.553695

Solheim KN, Esakoff TF, Little SE, Cheng YW, Sparks TN, Caughey AB. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med. 2011;24(11):1341-6. https://doi.org/10.3109/14767058.2011.553695

Higgins MF, Monteith C, Foley M, O'Herlihy C. Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur J Obstet Gynecol Reprod Biol. 2013;171(1):54-6. https://doi.org/10.1016/j.ejogrb.2013.08.030

Jauniaux E, Alfirevic Z, Bhide A, Belfort M, Burton G, Collins S, et al. Pla-centa praevia and placenta accreta: Diagnosis and management. BJOG: Int J Obstet Gynaecol. 2018;126(1):e1-48. https://doi.org/10.1111/1471-0528.15306

Fecopen F. Racionalización del uso de la cesárea en Colombia. Consenso de la Federación Colombiana de Obstetricia y Ginecología (FECOLSOG) y la Federación Colombiana de Perinatología (FECOPEN). Rev Colomb Obstet Ginecol. 2014;65(2):139. https://doi.org/10.18597/rcog.62

Betran AP, Ye J, Moller AB, Souza JP, Zhang J. Trends and projections of caesarean section rates: Global and regional estimates. BMJ Glob Health. 2021;6(6):e005671. https://doi.org/10.1136/bmjgh-2021-005671 PMID: 34130991; PMCID: PMC8208001

Fonseca A, Ayres de Campos D. Maternal morbidity and mortality due to placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2021;72:84-91. https://doi.org/10.1016/j.bpobgyn.2020.07.011

Jauniaux E, Silver RM. Moving from intra partum to prenatal diagnosis of placenta accreta: A quarter of a century in the making but still a long road to go. BJOG. 2017;124(1):96. https://doi.org/10.1111/1471-0528.14167

Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: A systematic review and meta-analysis. Am J Obstet Gynecol. 2017;217(1):27-36. https://doi.org/10.1016/j.ajog.2017.02.050

Silveira C, Kirby A, Melov SJ, Nayyar R. Placenta accreta spectrum: We can do better. Aust N Z J Obstet Gynaecol. 2022. https://doi.org/10.1111/ajo.13471

Aguilera LR, Mojica-Palacios LM, Urquizu F, Gorena M, Tinajeros Guzmán F, Vergara Galliadi LM, et al. Difficulties in the management of placenta ac-creta spectrum in hospitals with limited resources. Rev Bras Ginecol Obs-tet. 2022;44(5):467-74. https://doi.org/10.1055/s-0042-1742408

Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet. 2018;140(3):291-8. https://doi.org/10.1002/ijgo.12410

Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet. 2018;140(3):281-90. http://doi.org/10.1002/ijgo.12409

Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Martínez M, Bruno C. Placenta accreta spectrum: A hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J Matern Fetal Neonatal Med. 2022;35(2):275-82. https://doi.org/10.1080/14767058.2020.1716715

Hussein AM, Elbarmelgy RA, Elbarmelgy RM, Thabet MM, Jauniaux E. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder. Ultrasound Obstet Gynecol. 2022;59(4):474-82. https://doi.org/10.1002/uog.23732

Al-Omari W, Elbiss HM, Hammad FT. Placenta percreta invading the urinary bladder and parametrium. J Obstet Gynaecol. 2012;32(4):396-7. https://doi.org/10.3109/01443615.2012.665518

Kingdom JC, Hobson SR, Murji A, Allen L, Windrim RC, Lockhart E, et al. Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: The state of play in 2020. Am J Obstet Gynecol. 2020;223(3):322-9. https://doi.org/10.1016/j.ajog.2020.01.044

Nieto-Calvache AJ, Palacios-Jaraquemada JM, Aryananda RA, Rodriguez F, Ordoñez CA, Messa Bryon A, et al. How to identify patients who require aortic vascular control in placenta accreta spectrum disorders? Am J Obstet Gynecol. 2022;4(1):100498. https://doi.org/10.1016/j.ajogmf.2021.100498

Palacios-Jaraquemada JM. Comprehensive surgical staging for placenta accreta spectrum. JMFNM. Article in press, 2022.

Instituto Mexicano del Seguro Social. Diagnóstico y manejo de las anomalías en la inserción placentaria y vasa previa Guía de Práctica Clínica: Evidencias y Recomendaciones. 2019. mss.gov.mx; [citado el 8 de abril de 2022]. Disponible en: http://imss.gob.mx/profesionales-salud/gpc

Ministerio de Salud Pública. Anomalías de la inserción placentaria y vasos sanguíneos fetales. Guía de Práctica Clínica. Quito: Dirección Nacional de Normatización- MSP; 2017. Gob.ec. [citado el 8 de abril de 2022]. Disponible en: http://salud.gob.ec

Alves ÁLL, Silva LB da, Costa F da S, Rezende G de C. Management of placenta accreta spectrum: Number 9 - September 2021. Rev Bras Ginecol Obstet. 2021;43(9):713-23. https://doi.org/10.1055/s-0041-1736371

Maaløe N, Ørtved A, Sørensen JB. The injustice of unfit clinical practice guidelines in low-resource realities [published correction appears in Lancet Glob Health]. Lancet Glob Health. 2021;9(6):e875-9. https://doi.org/10.1016/S2214-109X(21)00059-0

Stokes T, Shaw EJ, Camosso-Stefinovic J, Imamura M, Kanguru L, Hussein J. Barriers and enablers to guideline implementation strategies to improve obstetric care practice in low- and middle-income countries: A systematic review of qualitative evidence. Implement Sci. 2016;11(1):144. https://doi.org/10.1186/s13012-016-0508-1

Brown AD, Hart JM, Modest AM, Hess PE, Abbas AM, Nieto-Calvache AJ, et al. Geographic variation in management of patients with placenta accreta spectrum: An international survey of experts (GPASS). Int J Gynaecol Obstet. 2021. https://doi.org/10.1002/ijgo.13960

Nieto-Calvache AJ, Palacios-Jaraquemada JM, Hidalgo A, Vergara-Galliadi LM, Cortés Charry R, Aguilera Daga LR, et al. Management practices for placenta accreta spectrum patients: A Latin American hospital survey. J Matern Fetal Neonatal Med. 2021;1-8. https://doi.org/10.1080/14767058.2021.1906858

Shamshirsaz AA, Fox KA, Erfani H, Belfort MA. The role of centers of excellence with multidisciplinary teams in the management of abnormal invasive placenta. Clin Obstet Gynecol. 2018;61(4):841-50. https://doi.org/10.1097/GRF.0000000000000393

Nieto-Calvache AJ, López-Girón MC, Nieto-Calvache A, Messa-Bryon A, Benavides-Calvache JP, Burgos-Luna JM. A nationwide survey of centers with multidisciplinary teams for placenta accreta patient care in Colombia, observational study. J Matern Fetal Neonatal Med. 2022;35(12):2331-7. https://doi.org/10.1080/14767058.2020.1786052

Muñoz LA, Mendoza GJ, Gómez M, Reyes LE, Arévalo JJ. Anesthetic management of placenta accreta in a low-resource setting: A case series. Int J Obstet Anesth. 2015;24(4):329-34. https://doi.org/10.1016/j.ijoa.2015.05.005

Jones J, Hunter D, Hasson F, Keeney S, Mckenna H. Consensus methods for medical and health services research. J Adv Nurs. 1995;311(7001):1008-15. https://doi.org/10.1136/bmj.311.7001.376

Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique: Delphi survey technique. J Adv Nurs. 2000;32(4):1008-15. https://doi.org/10.1046/j.1365-2648.2000.t01-1-01567.x

Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, et al., International Society for Abnormally Invasive Placenta (IS-AIP). Evidence-based guidelines for the management of abnormally invasive placenta: Recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220(6):511-526. https://doi.org/10.1016/j.ajog.2019.02.054

American College of Obstetricians and Gynecologists; Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2018;132(6):e259-e275. https://doi.org/10.1097/AOG.0000000000002983

Jauniaux E, Alfirevic Z, Bhide A, Belfort M, Burton G, Collins S, et al. Pla-centa praevia and placenta accreta: Diagnosis and management. BJOG: Int J Obstet Gynaecol. 2018;126(1):e1-48. https://doi.org/10.1111/1471-0528.15306

Silver RM, Fox KA, Barton JR, Abuhamad AZ, Simhan H, Huls CK, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol. 2015;212(5):561-8. https://doi.org/10.1016/j.ajog.2014.11.018

Coutinho CM, Giorgione V, Noel L, Liu B, Chandraharan E, Pryce J, et al. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery. Ultrasound Obstet Gynecol. 2021;57(1):91-6. https://doi.org/10.1002/uog.23100

Nieto-Calvache AJ, Velásquez P, Aguilera R, Aryananda RA, Hidalgo A. Placenta accreta spectrum: Intraoperatory analysis for immediate tele-help. J Matern Fetal Neonatal Med. 2022;1-4. https://doi.org/10.1080/14767058.2022.2029399

Chandraharan E, Hartopp R, Thilaganathan B, Coutinho CM. How to set up a regional specialist referral service for Placenta Accreta Spectrum (PAS) disorders? Best Pract Res Clin Obstet Gynaecol. 2021;72:92-101. https://doi.org/10.1016/j.bpobgyn.2020.07.007

Salmanian B, Shamshirsaz AA, Fox KA, Asl NM, Erfani H, Detlefs SE, et al. Clinical outcomes of a false-positive antenatal diagnosis of placenta accreta spectrum. Am J Perinatol. 2021. https://doi.org/10.1055/a-1673-5103

Ministerio de Salud y Protección Social (2019, 3 de octubre). Resolución 2654 de 2019. Por la cual se establecen disposiciones para la telesalud y parámetros para la práctica de la telemedicina en el país. Gov.co. [citado el 29 de abril de 2022]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/resolucion-2654-de-2019.pdf

Nieto Calvache AJ, Hidalgo A, López MC, Vergara-Galliadi LM, Nieto-Calvache AS. Placenta accreta spectrum in vulnerable population: How to provide care for pregnant refugees struggling to access affordable healthcare. J Matern Fetal Neonatal Med. 2021;1-4. https://doi.org/10.1080/14767058.2021.1874906

Sandlin AT, Magann EF, Whittington JR, Schneider AM, Ramseyer AM, Hughes, DS, et al. Management of pregnancies complicated by placenta accreta spectrum utilizing a multidisciplinary care team in a rural state [published online ahead of print, 2021 Mar 26]. J Matern Fetal Neonatal Med. 2021;1-6. https://doi.org/10.1080/14767058.2021.1903425

Ministerio de Salud y Protección Social. Colombia: lineamiento técnico y operativo de la ruta Integral de atención en salud Materno perinatal. http://idsn.gov.co/site/web2/images/documentos/sreproductiva/2018/Lineamiento_Ruta__Materno_Perinatal.pdf

Shamshirsaz AA, Fox KA, Erfani H, Clark SL, Salmanian B, Baker BW, et al. Multidisciplinary team learning in the management of the morbidly adherent placenta: Outcome improvements over time. Am J Obstet Gynecol. 2017;216(6):612.e1-612.e5. https://doi.org/10.1016/j.ajog.2017.02.016

Nieto-Calvache, A. J., Vergara-Galliadi, L. M., Rodríguez, F., Ordoñez, C. A., García, A. F., López, M. C., et al . A multidisciplinary approach and implementation of a specialized hemorrhage control team improves outcomes for placenta accreta spectrum. J Trauma Acute Care surg, 2021:90(5):807-816. https://doi.org/10.1097/TA.0000000000003090

Main EK, Goffman D, Scavone BM, Low LK, Bingham D, Fontaine PL, et al. National Partnership for Maternal Safety: consensus bundle on obstetric hemorrhage. Anesth Analg. 2015;121(1):142-8. https://doi.org/10.1097/AOG.0000000000000869

Nieto-Calvache AJ, Zambrano MA, Herrera NA, Usma A, Bryon AM, Benavides Calvache JP, et al. Resective-reconstructive treatment of abnormally invasive placenta: Inter Institutional Collaboration by telemedicine (eHealth). J Matern Fetal Neonatal Med. 2021;34(5):765-73. Disponible en: http://doi.org/10.1080/14767058.2019.1615877

Nieto-Calvache AJ, Palacios-Jaraquemada JM, Aguilera LR, Arriaga W, Colonia A, Aryananda RA, et al. Telemedicine facilitates surgical training in placenta accreta spectrum. Int J Gynaecol Obstet. 2021;158(1):137-44. https://doi.org/10.1002/ijgo.14000

Nieto-Calvache AJ. Training facilitated by interinstitutional collaboration and telemedicine: An alternative for improving results in the placenta accreta spectrum. AJOG Global Reports. 2021;1(Issue 4):100028. https://doi.org/10.1016/j.xagr.2021.100028

Nieto-Calvache AJ, Palacios Jaraquemada JM, Basanta N, Aryananda RA, Sinisterra-Díaz SE, Rodriguez F, et al. Internal manual compression of the aorta-an effective way to temporarily control pelvic bleeding in obstetrical hemorrhage. Am J Obstet Gynecol. 2022;227(1):96-7. https://doi.org/10.1016/j.ajog.2022.02.040

Carvajal JA, Ramos I, Kusanovic JP, Escobar MF. Damage-control resuscitation in obstetrics. J Matern Fetal Neonatal Med. 2022;35(4):785-98. https://doi.org/10.1080/14767058.2020.1730800

Pelosi MA 3rd, Pelosi MA. Modified cesarean hysterectomy for placenta previa percreta with bladder invasion: Retrovesical lower uterine segment bypass. Obstet Gynecol. 1999;93(5 Pt 2):830-3. Disponible en: https://doi.org/10.1016/S0029-7844(98)00426-8

Ward CR. Avoiding an incision through the anterior previa at cesarean delivery. Obstet Gynecol. 2003;102(3):552-4. https://doi.org/10.1016/S0029-7844(03)00625-2

Nieto-Calvache AJ, Palacios-Jaraquemada JM, Osanan G, Cortés-Charry R, Aryananda RA, Bangal VB, et al. Lack of experience is a main cause of maternal death in placenta accreta spectrum patients. Acta Obstet Gynecol Scand. 2021;100(8):1445-53. https://doi.org/10.1111/aogs.14163

Complex obstetric surgery fellowship. Utoronto.ca. Disponible en: https://obgyn.utoronto.ca/complex-obstetric-surgery-fellowship

The Fetal Medicine Foundation. Placenta Accreta Spectrum - FMF Courses. Fetalmedicine.com. [citado 2022 abr 29]. Disponible en: https://courses.fetalmedicine.com/fmf/show/1024

Nieto-Calvache AJ, Maya J, Vergara Galliadi LM, Nieto Calvache AS. Low-cost or free access virtual platforms utility in placenta accreta spectrum. AJOG Global Reports. 2022;2(1):100048. https://doi.org/10.1016/j.xagr.2021.100048

Sentilhes L, Seco A, Azria E, Beucher G, Bonnet M-P, Branger B, et al. Conservative management or cesarean hysterectomy for placenta accreta spectrum: the PACCRETA prospective study. Am J Obstet Gynecol. 2021;226(6):839.e1-839e24. https://doi.org/10.1016/j.ajog.2021.12.013

Majd S, Collins H, Addley SL. The modified radical peripartum cesarean hysterectomy (Soleymani-Alazzam-Collins technique): A systematic, safe procedure for the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2021;225(2). https://doi.org/10.1016/j.ajog.2021.03.014

Zuckerwise LC, Craig AM, Newton JM, Zhao S, Bennett KA, Crispens MA. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2020;222(2):179.e1-179.e9. https://doi.org/10.1016/j.ajog.2019.08.035

Hussein AM, Kamel A, Raslan A, Dakhly DMR, Abdelhafeez A, Nabil M, et al. Modified cesarean hysterectomy technique for management of cases of placenta increta and percreta at a tertiary referral hospital in Egypt. Arch Gynecol Obstet. 2019;299(3):695-702. https://doi.org/10.1007/s00404-018-5027-7

Matsubara S, Takahashi H, Horie K, Lefor AK, Fujiwara H. Caesarean hysterectomy for placenta accreta: Paracervix should be divided sequentially, not en masse. Eur J Obstet Gynecol Reprod Biol. 2016;201:227-8. https://doi.org/10.1016/j.ejogrb.2016.03.047

Palacios-Jaraquemada JM, Basanta N, Fiorillo A, Labrousse C, Martínez M. Neonatal outcome after conservative-reconstructive surgery for placenta accreta spectrum disorders. J Matern Fetal Neonatal Med. 2021;1-3. https://doi.org/10.1080/14767058.2021.1873944

Palacios-Jaraquemada JM, Basanta N, Labrousse C, Martínez M. Pregnancy outcome in women with prior placenta accreta spectrum disorders treated with conservative-reconstructive surgery: Analysis of 202 cases. J Matern Fetal Neonatal Med. 2021;1-5. https://doi.org/10.1080/14767058.2021.1910671

Shainker SA, Zuckerwise LC, Shamshirsaz AA. Conservative management of placenta accreta spectrum: is it time? Am J Obstet Gynecol. 2022;226(6):871. https://doi.org/10.1016/j.ajog.2022.01.007

Kingdom JC, Hobson SR, Murji A, Allen L, Windrim RC, Lockhart E, et al. Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: The state of play in 2020. Am J Obstet Gynecol. 2020;223(3):322-9. https://doi.org/10.1016/j.ajog.2020.01.044

How to Cite

1.
Nieto-Calvache AJ, Sanín-Blair JE, Buitrago-Leal HM, Benavides-Serralde JA, Maya-Castro J, Rozo-Rangel AP, et al. Colombian Consensus on the Treatment of Placenta Accreta Spectrum (PAS). Rev. colomb. obstet. ginecol. [Internet]. 2022 Sep. 30 [cited 2024 May 18];73(3):283-316. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/3877

Downloads

Download data is not yet available.

Published

2022-09-30
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo

Some similar items: